Immix Biopharma, Inc. IMMX Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $79.25M+398% | $93.93M+431% | $15.95M-19.0% | $11.64M-51.5% | $15.92M-45.7% | ||
| —— | —— | —— | —— | —— | ||
| $92.27M+450% | $101.24M+401% | $16.58M-27.1% | $12.33M-54.9% | $16.78M-49.0% | ||
| $2.43M+14.3% | $2.52M+44.9% | $2.36M+74.0% | $2.23M+391% | $2.12M+489% | ||
| $95.82M+382% | $104.84M+357% | $20.08M-20.1% | $15.64M-45.8% | $19.89M-42.1% | ||
| $4.73M-17.6% | $5.44M+1.0% | $7.05M+114% | $6.61M+182% | $5.74M+63.5% | ||
| $10.54M+13.2% | $10.11M+16.4% | $10.85M+65.3% | $10.01M+157% | $9.31M+64.5% | ||
| $11.45M+11.2% | $11.04M— | $11.82M— | $10.98M— | $10.3M— | ||
| 200M0.0% | 200M0.0% | 200M0.0% | 200M0.0% | 200M0.0% | ||
| -$114.55M-44.0% | -$104.46M-39.2% | -$93.78M-33.6% | -$86.19M-36.7% | -$79.57M-35.6% | ||
| $84.36M+779% | $93.8M+608% | $8.26M-52.9% | $4.65M-80.5% | $9.59M-65.6% | ||
| $95.82M+382% | $104.84M+357% | $20.08M-20.1% | $15.64M-45.8% | $19.89M-42.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Immix Biopharma, Inc.'s total assets?
- Immix Biopharma, Inc. (IMMX) holds $95.8M in total assets, up 381.7% year over year.
- How much debt does Immix Biopharma, Inc. have?
- Immix Biopharma, Inc. carries $1.0M in total debt against $84.4M of shareholders' equity, a debt-to-equity ratio of 0.01.
- How much cash does Immix Biopharma, Inc. have?
- Immix Biopharma, Inc. holds $79.3M in cash and equivalents.
- Can Immix Biopharma, Inc. cover its short-term obligations?
- Its current ratio is 8.76 — current assets exceed current liabilities.
- Where does Immix Biopharma, Inc.'s balance sheet data come from?
- Every line is extracted from Immix Biopharma, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.